<DOC>
	<DOCNO>NCT00435175</DOCNO>
	<brief_summary>Estradiol promote maintains typical female phenotype characterize subcutaneous fat accumulation . There evidence suggest effect relies ability estradiol increase amount anti-lipolytic α2A-adrenergic receptor , whether require long-term exposure estradiol result immediate effect clear . Objective : To study acute effect single dose ( 4 mg ) 17β-estradiol regional systemic lipolysis .</brief_summary>
	<brief_title>Acute Metabolic Effects Estradiol</brief_title>
	<detailed_description>Estradiol affect muscle fat distribution , thereby lipid metabolism . A reduction muscle power see menopause , readily counteract female hormone therapy ( HT ) . Treatment HT month previously untreated postmenopausal woman , hormone replacement therapy ( HRT ) woman Turner syndrome , increase muscle mass reduces fat mass . HT postmenopausal woman furthermore prevents fat accumulation increase lipoprotein lipase activity lipolysis extent comparable premenopausal woman . In contrast , also show estradiol may actually attenuate lipolysis basal well catecholamine stimulate condition . In addition , one study find whole body fat metabolism lower treatment estradiol without , reduce lipolysis present postmenopausal woman treatment estradiol , along increase number α-adrenergic receptor decrease number β-adrenergic receptor . It clear whether lipolytic effect estradiol happen acutely dependent chronic exposure . Moreover , regional difference pharmacodynamics estradiol assess . Finally , effect skeletal muscle never examine . The purpose present study 1 ) microdialysis quantify regional production glycerol two tissue ( muscle fat ) , two region ( abdominal femoral ) . 2 ) To quantify whole-body lipolytic effect estradiol , 3 ) biopsy study intracellular mechanism behind action estradiol .</detailed_description>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Postmenopausal woman assess FSH estradiol level Not take drug Nonsmokers Obesity ( BMI &gt; 30 )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Estradiol</keyword>
	<keyword>Lipolysis</keyword>
	<keyword>Estrogen receptor</keyword>
	<keyword>Adrenergic receptor</keyword>
	<keyword>UCP2</keyword>
	<keyword>Postmenopausal woman</keyword>
</DOC>